HL7 FHIR Implementation Guide: Breast Cancer Data, Release 1 - US Realm (Draft for Comment 2)
This page is part of the Breast Cancer Data Logical Models and FHIR Profiles (v0.2.0: STU 1 Draft) based on FHIR R3. . For a full list of available versions, see the Directory of published versions 
Definitions for oncology-ProgesteroneReceptorNuclearPositivity-model.
| oncology-ProgesteroneReceptorNuclearPositivity-model | |
| Definition | The percentage of cells that test (stain) positive for the presence of progesterone receptors. We are seeking feedback on whether nuclear positivity should be an exact percentage or a range of percentages. As currently defined, an exact nuclear positivity could be represented by a zero-width range, where the lower and upper bounds would be the same number. We are seeking feedback on whether nuclear positivity should be an exact percentage or a range of percentages. As currently defined, an exact nuclear positivity could be represented by a zero-width range, where the lower and upper bounds would be the same number. |
| Control | 0..* |
| oncology-ProgesteroneReceptorNuclearPositivity-model.value | |
| Definition | Range representing the percentage of cells that test (stain) positive for the presence of progesterone receptors. We are seeking feedback on whether nuclear positivity should be an exact percentage or a range of percentages. As currently defined, an exact nuclear positivity could be represented by a zero-width range, where the lower and upper bounds would be the same number. We are seeking feedback on whether nuclear positivity should be an exact percentage or a range of percentages. As currently defined, an exact nuclear positivity could be represented by a zero-width range, where the lower and upper bounds would be the same number. |
| Control | 1..1 |
| Type | http://hl7.org/fhir/us/breastcancer/StructureDefinition/shr-core-Range-model |
| oncology-ProgesteroneReceptorNuclearPositivity-model.topicCode | |
| Definition | The concept representing the finding or action that is the topic of the statement. For action topics, the TopicCode represents the action being described. For findings, the TopicCode represents the 'question' or property being investigated. For evaluation result findings, the TopicCode contains a concept for an observable entity, such as systolic blood pressure. For assertion findings, the TopicCode contains a code representing the condition, allergy, or other item being asserted. In all cases, the TopicCode describes the topic independent of the context of the action or the finding. |
| Control | 0..1 |
| Type | Coding |
| oncology-ProgesteroneReceptorNuclearPositivity-model.exceptionValue | |
| Definition | Reason that a value associated with a test or other finding is missing. |
| Control | 0..1 |
| Binding | The codes SHALL be taken from DataAbsentReason; other codes may be used where these codes are not suitable |
| Type | Coding |
| oncology-ProgesteroneReceptorNuclearPositivity-model.interpretation | |
| Definition | A clinical interpretation of a finding (applies to both assertions and observation). |
| Control | 0..1 |
| Binding | The codes SHALL be taken from Observation Interpretation Codes; other codes may be used where these codes are not suitable |
| Type | Coding |
| oncology-ProgesteroneReceptorNuclearPositivity-model.referenceRange | |
| Definition | The usual or acceptable range for a test result. |
| Control | 0..0 |
| Type | http://hl7.org/fhir/us/breastcancer/StructureDefinition/cimi-topic-ReferenceRange-model |